Quarterly report pursuant to Section 13 or 15(d)

RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS - RESTATED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' (DEFICIT) EQUITY (Details)

v3.24.3
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS - RESTATED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' (DEFICIT) EQUITY (Details) - USD ($)
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Balance beginning $ (15,158,968) $ 8,153,244
Balance beginning Series D preferred stock 1,382,023  
Stock-based compensation 454,363 408,206
Exercise of warrants into common shares 2,298,143  
Net loss (26,641,983) (7,190,470)
Balance ending Series D preferred stock $ 1,382,023  
Balance ending Series D preferred stock (in shares) 111.11  
Balance ending $ 12,501,095 1,370,983
As previously reported    
Balance beginning (1,356,047)  
Stock-based compensation 454,363  
Exercise of warrants into common shares 1,072,467  
Settlement of warrants to equity (Note 2) 4,800,000  
Net loss (21,581,637)  
Balance ending 26,166,146  
Restatement adjustments    
Balance beginning (13,802,921)  
Exercise of warrants into common shares 1,225,676  
Net loss (5,060,346)  
Balance ending Series D preferred stock 1,382,023  
Balance ending (13,665,051)  
Series D preferred stock    
Balance beginning Series D preferred stock $ 1,382,023 $ 1,382,023
Balance beginning Series D preferred stock (in shares) 111.11 111.11
Balance ending Series D preferred stock $ 1,382,023 $ 1,382,023
Balance ending Series D preferred stock (in shares) 111.11 111.11
Series D preferred stock | Restatement adjustments    
Balance beginning Series D preferred stock $ 1,382,023  
Balance beginning Series D preferred stock (in shares) 111.11  
Balance ending Series D preferred stock $ 1,382,023  
Balance ending Series D preferred stock (in shares) 111.11  
Preferred Stock    
Balance beginning $ 4,677,632  
Balance beginning (in shares) 319.76  
Balance ending $ 17,067,715  
Balance ending (in shares) 867.50  
Preferred Stock | As previously reported    
Balance beginning $ 6,059,655  
Balance beginning (in shares) 430.87  
Balance ending $ 17,078,309  
Balance ending (in shares) 978.61  
Preferred Stock | Restatement adjustments    
Balance beginning $ (1,382,023)  
Balance beginning (in shares) (111.11)  
Settlement of warrants to equity (Note 2) $ 4,800,000  
Balance ending $ (10,594)  
Balance ending (in shares) (111.11)  
Preferred Stock | Series E-2 preferred stock    
Conversion of preferred stock to common stock $ (1,203,346)  
Conversion of preferred stock to common stock (in shares) (82.26)  
Preferred Stock | Series E-2 preferred stock | As previously reported    
Conversion of preferred stock to common stock $ (1,203,346)  
Conversion of preferred stock to common stock (in shares) (82.26)  
Preferred Stock | Series E-3 preferred stock    
Conversion of preferred stock to common stock $ (33,983,571)  
Conversion of preferred stock to common stock (in shares) (1,575.00)  
Preferred Stock | Series E-3 preferred stock | As previously reported    
Conversion of preferred stock to common stock $ (30,555,000)  
Conversion of preferred stock to common stock (in shares) (1,575.00)  
Preferred Stock | Series E-3 preferred stock | Restatement adjustments    
Conversion of preferred stock to common stock $ (3,428,571)  
Common Stock    
Balance beginning $ 207 $ 94
Balance beginning (in shares) 20,744,110 9,385,272
Exercise of warrants into common shares $ 5  
Exercise of warrants into common shares (in shares) 547,177  
Retired shares (in shares) (8)  
Balance ending $ 332 $ 97
Balance ending (in shares) 33,164,466 9,740,507
Common Stock | As previously reported    
Balance beginning $ 207  
Balance beginning (in shares) 20,744,110  
Exercise of warrants into common shares $ 5  
Exercise of warrants into common shares (in shares) 547,177  
Retired shares (in shares) (8)  
Balance ending $ 332  
Balance ending (in shares) 33,164,466  
Common Stock | Series E-2 preferred stock    
Conversion of preferred stock to common stock $ 9  
Conversion of preferred stock to common stock (in shares) 903,956  
Common Stock | Series E-2 preferred stock | As previously reported    
Conversion of preferred stock to common stock $ 9  
Conversion of preferred stock to common stock (in shares) 903,956  
Common Stock | Series E-3 preferred stock    
Conversion of preferred stock to common stock $ 100  
Conversion of preferred stock to common stock (in shares) 9,890,099  
Common Stock | Series E-3 preferred stock | As previously reported    
Conversion of preferred stock to common stock $ 100  
Conversion of preferred stock to common stock (in shares) 9,890,099  
Additional Paid-In Capital    
Balance beginning $ 182,924,210 $ 168,143,557
Stock-based compensation 454,363 408,206
Exercise of warrants into common shares 2,298,138  
Balance ending 224,836,048 168,551,763
Additional Paid-In Capital | As previously reported    
Balance beginning 210,066,630  
Stock-based compensation 454,363  
Exercise of warrants into common shares 1,072,462  
Settlement of warrants to equity (Note 2) 4,800,000  
Balance ending 248,151,681  
Additional Paid-In Capital | Restatement adjustments    
Balance beginning (27,142,420)  
Exercise of warrants into common shares 1,225,676  
Settlement of warrants to equity (Note 2) (4,800,000)  
Balance ending (23,315,633)  
Additional Paid-In Capital | Series E-2 preferred stock    
Conversion of preferred stock to common stock 1,203,337  
Additional Paid-In Capital | Series E-2 preferred stock | As previously reported    
Conversion of preferred stock to common stock 1,203,337  
Additional Paid-In Capital | Series E-3 preferred stock    
Conversion of preferred stock to common stock 33,983,471  
Additional Paid-In Capital | Series E-3 preferred stock | As previously reported    
Conversion of preferred stock to common stock 30,554,900  
Additional Paid-In Capital | Series E-3 preferred stock | Restatement adjustments    
Conversion of preferred stock to common stock 3,428,571  
Accumulated Deficit    
Balance beginning (202,761,017) (159,990,407)
Net loss (26,641,983) (7,190,470)
Balance ending (229,403,000) (167,180,877)
Accumulated Deficit | As previously reported    
Balance beginning (217,482,539)  
Net loss (21,581,637)  
Balance ending (239,064,176)  
Accumulated Deficit | Restatement adjustments    
Balance beginning 14,721,522  
Net loss (5,060,346)  
Balance ending 9,661,176  
Pre-funded warrants    
Conversion of preferred stock to common stock 3,972,540 3
Pre-funded warrants | Restatement adjustments    
Conversion of preferred stock to common stock 3,972,540  
Pre-funded warrants | Common Stock    
Conversion of preferred stock to common stock $ 11 $ 3
Conversion of preferred stock to common stock (in shares) 1,079,132 355,235
Pre-funded warrants | Common Stock | As previously reported    
Conversion of preferred stock to common stock $ 11  
Conversion of preferred stock to common stock (in shares) 1,079,132  
Pre-funded warrants | Additional Paid-In Capital    
Conversion of preferred stock to common stock $ 3,972,529  
Pre-funded warrants | Additional Paid-In Capital | As previously reported    
Conversion of preferred stock to common stock (11)  
Pre-funded warrants | Additional Paid-In Capital | Restatement adjustments    
Conversion of preferred stock to common stock 3,972,540  
Tranche A Warrants    
Exercise of warrants into common shares 47,577,000  
Tranche A Warrants | As previously reported    
Exercise of warrants into common shares 42,777,000  
Tranche A Warrants | Preferred Stock    
Exercise of warrants into common shares $ 47,577,000  
Exercise of warrants into common shares (in shares) 2,205.00  
Tranche A Warrants | Preferred Stock | As previously reported    
Exercise of warrants into common shares $ 42,777,000  
Exercise of warrants into common shares (in shares) 2,205.00